Herbal hope: ashwagandha trial targets minority stress in LGBTQ+ community
NCT ID NCT07441070
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a daily ashwagandha supplement can lower stress, anxiety, and improve sleep in 80 LGBTQ+ adults aged 18-45 who report high stress. Participants take either ashwagandha capsules or a placebo for 8 weeks, and researchers track changes using questionnaires and a stress hormone test. The goal is to find a safe, non-drug option for managing the chronic stress linked to stigma and discrimination.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ashwagandha root extract (dietary supplement)
What this could lead to
If it works, this could offer a natural, non-prescription option to help LGBTQ+ adults manage stress and sleep problems.
What could go wrong
This is a small, early-stage study. Supplements are not strictly regulated, and results may not apply to everyone. The placebo effect could be strong.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
San Francisco Research Institute
RECRUITINGSan Francisco, California, 94132, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••